Sigma Healthcare Director Alters Shareholding

The latest announcement is out from Sigma Healthcare Ltd ( (AU:SIG) ).

Sigma Healthcare Ltd has announced a significant change in the shareholding interests of its director, Danielle Di Pilla. Over the course of four days in May 2025, Di Pilla disposed of a substantial number of shares, reducing her direct holdings from 61,243,218 to 31,401,068 ordinary shares. This change, executed through on-market trades, reflects a strategic decision that may impact the company’s stock market presence and influence shareholder perceptions.

The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.45 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.

More about Sigma Healthcare Ltd

Sigma Healthcare Ltd operates in the healthcare industry, focusing on the distribution of pharmaceutical products and services. The company is a key player in the Australian market, providing a range of healthcare solutions to pharmacies and hospitals.

Average Trading Volume: 35,129,171

Technical Sentiment Signal: Buy

Current Market Cap: A$36.4B

For a thorough assessment of SIG stock, go to TipRanks’ Stock Analysis page.